On the HCPLive Family Medicine condition center page, resources on the topics of medical news and expert insight into family care can be found. Content includes articles, interviews, videos, podcasts, and breaking news on Family medicine research, treatment, and drug development.
April 29th 2024
A combination of telemedicine and in-person visits led to a nearly 6% increase in electronic health record work for primary care physicians.
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
All-oral Drug Combination Delivers High Hepatitis C Cure Rates
May 12th 2014An all-oral antiviral drug combination that included ombitasvir and dasabuvir with and without ribavirin resulted in high cure rates among patients with hepatitis C virus infections in first-time treatments for the disease, according to an article published in the May 4, 2014, issue of the New England Journal of Medicine.
New Approach to Immunotherapy for Severe Peanut and other Food Allergies
Research from North Carolina's biggest universities that identified new ways to bind polyphenol-rich foods with peanut flour may one day help patients with severe food allergies develop increased tolerance without risking anaphylaxis.
Paliperidone Palmitate Delays Relapse in Patients with Schizoaffective Disorder
May 7th 2014Patients with schizoaffective disorder who were treated with paliperidone palmitate (as monotherapy and adjunctive therapy) experienced delayed time to relapse and reduced risk of relapse compared to patients treated with placebo.
ADHD Drug Also Produces Promising Results in Adults with Binge Eating Disorder
May 7th 2014Adult patients with binge eating disorder who were treated for 12 weeks with lisdexamfetamine dimesylate reported having 4 fewer binge days per week, and also experienced improvements in weight and triglyceride levels.
Bremelanotide Treatment Improves Sexual Function and Reduces Associated Distress Levels in Women
May 7th 2014Patients in a trial of a first-in-class medication for the treatment of female sexual dysfunction reported improvement in overall sexual function, including an increase in the number of satisfying sexual events, and a concomitant decrease in distress levels associated with sexual dysfunction.
Promising Results for First Pharmacologic Treatment for Celiac Disease
May 7th 2014Patients with celiac disease treated with larazotide acetate experienced improvements in GI symptoms and non-GI symptoms such as headache and fatigue, as well as significant reductions in the number of symptomatic days.
Patients Undergoing Dialysis Found to Have Atrial Fibrillation
A new study of atrial fibrillation patients who require regular dialysis found more episodes of irregular heartbeat on dialysis days - particularly when dialysis was actually taking place - than at other times.
Vortioxetine May Also Improve Cognition in Adult Patients with Major Depressive Disorder
May 6th 2014Study results presented at the 2014 APA annual meeting show patients treated with vortioxetine significant improvement in composite cognition scores compared to patients treated with placebo, independent of the drug's effect on their depression symptoms.
Triple Antiviral Therapy Achieves Near 100% Response in Patients with Hepatitis C Genotype 4
May 6th 2014An all-oral, ribavirin-free, interferon-free combination of three direct-acting antiviral agents that had achieved sustained virologic response in 92% of patients with chronic HCV genotype 1 infection has demonstrated even greater response in patients with genotype 4 infection.
Combination Treatment with Sofosbuvir plus Ledipasvir Highly Effective After Only Eight Weeks
May 6th 2014Treatment with an 8-week regimen of combination sofosbuvir plus ledipasvir with or without ribavirin produced sustained virologic response rates (SVR) similar to those achieved with a 12-week regimen in non-cirrhotic, previously untreated, genotype 1 hepatitis C patients, according to results from the ION-3 trial.
Desvenlafaxine Safe and Effective for Major Depressive Disorder in 'Real-world' Trial Setting
May 5th 2014Small, "naturalistic" study shows treatment with desvenlafaxine produces high rates of symptom improvement and remission with low rates of adverse events in patients with major depressive disorder.
Study Provides More Evidence that Statins Help Slow Liver Fibrosis in Hepatitis C
May 5th 2014Patients in the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial who were also treated with statins experienced a significant decrease in time to histological disease progression compared to patients who did not receive statin treatment.